GIST Specialist for Los Feliz, CA
Surgery for a gastrointestinal stromal tumor lasts a morning. The medication afterwards can last three years, and that is where most of the difficulty actually sits. Joshua Ellenhorn, MD, FACS treats the long stretch as part of the plan rather than someone else problem.
- Adjuvant duration decided on risk grading, not by default
- Clinical Professor of Surgery, Cedars-Sinai Medical Center
- Works closely with the oncologist managing your medication
- Twenty to twenty five minutes via Franklin and Highland
Three Years Is a Long Time to Take Anything
Imatinib is described as well tolerated, which is accurate relative to conventional chemotherapy and misleading as a description of daily life. Most people on it experience something: swelling around the eyes and ankles, fatigue, muscle cramps, nausea, rash, changes in bowel habit. Individually these are minor and none of them sounds like much on a consent form.
Sustained every day for three years, they add up differently. The fatigue in particular is difficult to convey to anyone who has not experienced it, partly because it does not show and partly because there is no number to point to. Patients describe managing perfectly well for eight or ten months and then finding it harder rather than easier.
What follows from that is the thing worth knowing: people stop. Quietly, without mentioning it, or by taking the drug intermittently in a way nobody asks about. That matters because the survival benefit demonstrated in the trials assumed the drug was actually taken. A three year prescription taken half the time is not a three year course, and the difference does not show up until a recurrence appears.
Almost all of these effects can be managed, and a reduced dose that someone sustains for three years is worth considerably more than a full dose abandoned after one. The essential thing is to raise it rather than endure it, and to raise it when it starts rather than at the next scheduled review.
Common Effects, and What They Usually Mean
This is orientation rather than instruction. Every one of these should be reported to the oncologist prescribing your medication, who will advise on management specific to you.
| Effect | What it typically involves | Worth knowing |
|---|---|---|
| Swelling around the eyes | Often the earliest effect. Puffiness worst in the morning | Reflects fluid shifting into soft tissue. Usually not harmful, but report it rather than assuming nothing can be done |
| Fatigue | Persistent tiredness disproportionate to activity | The most commonly underreported effect. A legitimate reason to request a dose review |
| Muscle cramps | Frequently in the legs and at night | Common and often improvable. Depends on your bloodwork and other medications, so advice should be individual |
| Nausea | Often eased by taking the dose with a meal and plenty of water | Timing relative to your largest meal is worth experimenting with under guidance |
| Rash | Usually mild and manageable | A widespread or blistering rash is different and warrants prompt contact rather than waiting |
| Changes in blood counts or liver tests | Detected on routine monitoring rather than felt | The reason regular bloodwork continues throughout treatment |
| Interactions | With some supplements, herbal products and grapefruit | Bring a complete list of everything you take, including anything bought without a prescription |
Anything sudden or severe, particularly breathlessness, significant swelling, or a widespread rash, warrants contacting your team the same day rather than at the next appointment.
The First Question Is Whether You Need It At All
Everything above assumes adjuvant therapy is indicated. For a substantial proportion of patients it is not, and being placed on three years of medication unnecessarily is its own harm.
The decision rests on risk grading from three things: tumor size, its site in the digestive tract, and the mitotic index from pathology. A small gastric tumor with a low mitotic count and an intact capsule sits at the bottom of every published risk table, and the appropriate treatment is surgery followed by a tapering surveillance schedule and no drug at all.
Mutation subtype matters equally. Tumors with a KIT exon 11 mutation benefit clearly. Exon 9 tumors need higher dosing to respond. PDGFRA D842V and SDH-deficient tumors derive little or no benefit from imatinib, which means prescribing it delivers the side effects described above with almost none of the protection.
So the useful question before starting is not how to cope with the drug but whether the grading and the mutation testing actually support taking it. If nobody has told you your risk category, that is where to begin.
The Surgery That Determines the Rest
Recordings of real GIST resections narrated by the surgeon who performed them. Capsule integrity, visible here, is one of the factors deciding whether medication is needed and for how long.
Laparoscopic Resection of a Gastric GIST
A gastric GIST removed through small incisions with the capsule kept intact, which keeps the adjuvant decision straightforward.
Gastric GIST Resection: A Simplified Approach
A refined approach that shortens operating time and recovery.
Robotic Resection of a Duodenal GIST
Duodenal GIST removed robotically with the pancreas and bile duct preserved.
Ask for an Adjustment Instead
If the side effects are becoming unmanageable, a dose reduction is a normal part of treating this disease. Stopping without telling anyone is the outcome that costs the most and the one clinicians see most often.
Certifications and Appointments
Two American Board of Surgery certifications, a Cedars-Sinai teaching appointment, and membership of the societies that publish the adjuvant guidance for this disease.
- American Board of Surgery, certified in General Surgery
- American Board of Surgery, certified in Colorectal Surgery
- California State Medical License
- Florida State Medical License
Joshua Ellenhorn, MD, FACS
Dr. Ellenhorn is a surgical oncologist and Clinical Professor of Surgery at Cedars-Sinai Medical Center, and a collaborative member of the Samuel Oschin Comprehensive Cancer Institute.
The medication is prescribed and monitored by medical oncology, and it should be. What a surgeon owes the process is making sure the decision is properly informed: that the mitotic index was counted, that mutation testing was ordered, that capsule integrity was documented, and that the risk category was actually calculated rather than assumed. Handing over an incomplete pathology report and considering the job finished is how patients end up on three years of a drug that was never going to help them.
He is certified by the American Board of Surgery in General Surgery and in Colorectal Surgery, a Fellow of the American College of Surgeons, and a member of the Society of Surgical Oncology and the American Society of Clinical Oncology. He practises with the Surgery Group of Los Angeles.
What Patients Say
Reviews left by patients treated by Dr. Ellenhorn at the Surgery Group of Los Angeles.
★★★★★I was very pleased with the office staff, they were always very pleasant and helpful. I was very impressed with Dr. Ellenhorn as well. He was very friendly and addressed all my concerns regarding my surgery and aftercare and follow up.
Terry Jackson
★★★★★The staff at the Surgery Group of Los Angeles are wonderful. They are kind, very attentive, the office is clean and I did not have to wait long at all. I cannot say enough great things about Dr. Ellenhorn. He is an excellent surgeon who is highly skilled and very knowledgeable. I cannot thank him enough for all he has done for my family and I.
Erika Frank
From Los Feliz
Los Feliz Boulevard west to Franklin, then Highland south and west along 3rd Street, is the usual route. The 101 south to Highland is comparable and often quicker off peak. From the Hillhurst and Vermont end, Beverly Boulevard west is the more direct line. Twenty to twenty five minutes generally.
The office is in the medical plaza attached to Cedars-Sinai Medical Center, where medical oncology sits within the same institution. For the subject of this page that adjacency is the practical point: the surgeon and the prescriber are working from one record, so the adjuvant decision is made on complete information rather than through correspondence.
Patients travelling from outside the region, including Arizona and Nevada, can have imaging and pathology reviewed remotely.
8635 W 3rd St, Suite 880W
Los Angeles, CA 90048
Monday to Saturday, 11:00am to 8:00pm
Closed Sunday
Frequently Asked Questions
Why are my eyes puffy on imatinib?
The fatigue is the hardest part. Is that normal?
What can be done about muscle cramps?
Does taking it with food help the nausea?
Can the dose be reduced rather than stopped?
Will I need regular blood tests?
Should I take supplements or herbal remedies alongside it?
How far is your office from Los Feliz?
Before Three Years of Medication, Check You Need It.
Risk grading and mutation subtype determine whether adjuvant therapy will help you. If nobody has explained either, that conversation comes before learning to live with the side effects.
